Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
KA - Kineta Inc - Stock Price Chart
TickerKA [NASD]
CompanyKineta Inc
Market Cap42.69MEPS (ttm)-20.85
P/E-EPS this Y87.65%
Forward P/E-EPS next Y9.43%
PEG-EPS past 5Y47.65%
P/S8.82EPS next 5Y-
P/B5.67EPS Q/Q-
Dividend-Sales Q/Q404.50%
Insider Own32.95%Inst Own13.66%
Insider Trans1.26%Inst Trans-14.18%
Short Float0.53%EarningsAug 11/a
Analyst Recom1.00Target Price8.00
Avg Volume26.61K52W Range1.78 - 15.54
IMMX - Immix Biopharma Inc - Stock Price Chart
CompanyImmix Biopharma Inc
Market Cap86.59MEPS (ttm)-0.81
P/E-EPS this Y-36.81%
Forward P/E-EPS next Y-6.36%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B5.41EPS Q/Q-111.19%
Dividend-Sales Q/Q-
Insider Own74.19%Inst Own3.23%
Insider Trans1.00%Inst Trans33.19%
Short Float1.42%Earnings-
Analyst Recom1.00Target Price11.00
Avg Volume167.08K52W Range0.68 - 4.51
Today 09:14AM Immix Biopharma Announces Complete Response in 9th Relapsed/Refractory AL Amyloidosis Patient in NXC-201 Clinical Trial at IMS 20th Annual Meeting (GlobeNewswire)
Oct-02-23 08:06AM Immix Biopharma Announces 72-Patient NXC-201 Clinical Data at the IMS 20th Annual Meeting, 95% Overall Response Rate in Multiple Myeloma (GlobeNewswire) +26.61%
Sep-22-23 12:04PM Immix (IMMX) Up on Orphan Drug Tag for AL Amyloidosis Therapy (Zacks)
Sep-21-23 08:55AM U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Amyloid Light Chain (AL) Amyloidosis (GlobeNewswire) +15.38%
Sep-19-23 09:10AM Immix Biopharma Subsidiary Nexcella Completes 2nd NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site (GlobeNewswire) +24.15%
Sep-15-23 01:18PM Director Helen Adams Buys 13,000 Shares of Immix Biopharma Inc (IMMX) ( +5.12%
Sep-07-23 10:38AM The 3 Best Speculative Stocks to Buy Now: September 2023 (InvestorPlace)
08:41AM Nexcella, Immix Biopharma Subsidiary, to Present at the Bank of America 2023 Healthcare Trailblazers Private Company Conference (GlobeNewswire)
Sep-01-23 08:39AM Immix Biopharma Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York, Joins Scientific Advisory Board (GlobeNewswire) +12.81%
Aug-23-23 08:37AM U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Multiple Myeloma (GlobeNewswire) +11.11%
EUDA - Euda Health Holdings Limited - Stock Price Chart
CompanyEuda Health Holdings Limited
IndustryHealth Information Services
Market Cap30.49MEPS (ttm)-0.14
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.20EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own34.37%Inst Own10.76%
Insider Trans0.00%Inst Trans0.61%
Short Float0.06%Earnings-
Analyst Recom-Target Price-
Avg Volume219.75K52W Range0.43 - 10.50
FEMY - Femasys Inc - Stock Price Chart
CompanyFemasys Inc
IndustryMedical Instruments & Supplies
Market Cap42.05MEPS (ttm)-0.97
P/E-EPS this Y10.68%
Forward P/E-EPS next Y43.15%
PEG-EPS past 5Y-
P/S35.04EPS next 5Y-
P/B3.27EPS Q/Q0.99%
Dividend-Sales Q/Q5.74%
Insider Own11.20%Inst Own7.51%
Insider Trans0.00%Inst Trans14.31%
Short Float0.60%EarningsAug 10/b
Analyst Recom1.00Target Price7.75
Avg Volume11.24M52W Range0.25 - 4.75
ALXO - Alx Oncology Holdings Inc - Stock Price Chart
CompanyAlx Oncology Holdings Inc
Market Cap295.25MEPS (ttm)-3.19
P/E-EPS this Y-4.40%
Forward P/E-EPS next Y-5.58%
PEG-EPS past 5Y-58.82%
P/S-EPS next 5Y-
P/B1.38EPS Q/Q-3.29%
Dividend-Sales Q/Q-
Insider Own55.28%Inst Own44.42%
Insider Trans-0.06%Inst Trans1.24%
Short Float16.48%EarningsAug 10/a
Analyst Recom1.33Target Price27.83
Avg Volume160.07K52W Range3.94 - 13.64
SASI - Sigma Additive Solutions Inc - Stock Price Chart
CompanySigma Additive Solutions Inc
IndustryInformation Technology Services
Market Cap1.63MEPS (ttm)-13.87
P/E-EPS this Y49.40%
Forward P/E1.67EPS next Y-
PEG-EPS past 5Y39.22%
P/S2.85EPS next 5Y-
P/B0.68EPS Q/Q43.17%
Dividend-Sales Q/Q-58.99%
Insider Own0.93%Inst Own9.51%
Insider Trans0.00%Inst Trans-
Short Float2.90%EarningsAug 14/a
Analyst Recom1.00Target Price20.00
Avg Volume90.58K52W Range2.77 - 18.90
FORA - Forian Inc. - Stock Price Chart
CompanyForian Inc.
IndustryHealth Information Services
Market Cap68.26MEPS (ttm)-0.46
P/E-EPS this Y81.48%
Forward P/E-EPS next Y33.33%
PEG-EPS past 5Y-
P/S2.75EPS next 5Y-
P/B3.27EPS Q/Q79.52%
Dividend-Sales Q/Q-25.11%
Insider Own49.38%Inst Own12.65%
Insider Trans0.28%Inst Trans-4.79%
Short Float2.06%EarningsAug 10/a
Analyst Recom1.00Target Price9.00
Avg Volume7.60K52W Range2.00 - 5.45
GRCL - Gracell Biotechnologies Inc ADR - Stock Price Chart
CompanyGracell Biotechnologies Inc ADR
Market Cap249.37MEPS (ttm)-1.28
P/E-EPS this Y17.64%
Forward P/E-EPS next Y-8.65%
PEG-EPS past 5Y-68.83%
P/S-EPS next 5Y-
P/B1.13EPS Q/Q6.03%
Dividend-Sales Q/Q-
Insider Own13.98%Inst Own28.74%
Insider Trans0.00%Inst Trans-4.29%
Short Float1.12%EarningsAug 14/b
Analyst Recom1.00Target Price12.71
Avg Volume246.22K52W Range1.40 - 6.99
Sep-27-23 08:30AM Gracell Biotechnologies Reports Updated Clinical Data for FasTCAR-T GC012F for High-Risk, Newly Diagnosed Multiple Myeloma, Demonstrating 100% Stringent Complete Response Rate (GlobeNewswire)
Sep-26-23 04:00PM Gracell Biotechnologies Doses First Patient in Phase 1b/2 Clinical Trial in U.S. Evaluating GC012F for Treatment of Relapsed/Refractory Multiple Myeloma (GlobeNewswire)
Sep-19-23 09:21AM Gracell Biotechnologies CEO Dr. William Cao Named to Prestigious PharmaVoice 100, Honoring Most Inspiring Life Science Leaders (GlobeNewswire)
Sep-14-23 09:15AM Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences (GlobeNewswire)
Sep-12-23 09:55AM Gracell Biotechnologies Inc. Sponsored ADR (GRCL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks) -6.06%
Sep-06-23 08:00AM Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 2023 International Myeloma Society Annual Meeting (PR Newswire)
Aug-24-23 04:10PM Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Aug-21-23 09:02PM RA Capital Management, L.P. Acquires Significant Stake in Gracell Biotechnologies Inc. (
Aug-15-23 12:51AM Q2 2023 Gracell Biotechnologies Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 07:15AM Gracell Biotechnologies Reports Second Quarter 2023 Unaudited Financial Results and Provides Corporate Update (GlobeNewswire)
FFIE - Faraday Future Intelligent Electric Inc - Stock Price Chart
CompanyFaraday Future Intelligent Electric Inc
IndustryAuto Manufacturers
Market Cap20.65MEPS (ttm)-1.05
P/E-EPS this Y78.00%
Forward P/E-EPS next Y45.45%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.07EPS Q/Q99.70%
Dividend-Sales Q/Q-
Insider Own7.60%Inst Own6.74%
Insider Trans0.00%Inst Trans-90.61%
Short Float25.19%EarningsAug 21/a
Analyst Recom-Target Price-
Avg Volume3.24M52W Range1.17 - 105.60
Oct-02-23 03:41AM Faraday Future Announces Latest FF 91 2.0 Futurist Alliance Delivery (Business Wire) -10.15%
Sep-29-23 12:11AM Faraday Future Announces its Outline for October FF 91 2.0 Deliveries as Part of its Ongoing Delivery Co-Creation Day Plan and Provides Business Update (Business Wire)
Sep-27-23 07:59PM Faraday Future to Host Investor Presentation Webcast (Business Wire) -44.31%
06:10AM Faraday Future Announces At-the-Market Equity Offering Program (Business Wire)
Sep-25-23 10:22PM Faraday Future Appoints Scott Graziano, Senior Legal Executive with Extensive U.S. Public Company Experience, as Global General Counsel (Business Wire) -24.23%
Sep-21-23 06:10PM Faraday Future Announces Management Stock Purchase Plan (Business Wire) -6.15%
04:30PM Faraday Future Announces Appointment of Matthias Aydt as Global Chief Executive Officer (Business Wire)
Sep-20-23 05:45AM Faraday Future Continues Deliveries, Today Delivering to Kelvin Sherman during the "919 Developers AI Co-Creation Festival", Announces its First Female User and Developer Co-Creation Officer Emma Hernan, and Regaining Nasdaq Compliance (Business Wire)
Sep-15-23 04:05AM Faraday Future to Deliver Another FF 91 2.0 Futurist Alliance, This Time to Celebrity Agent Kelvin Sherman at the Upcoming "919 Developers AI Co-Creation Festival" Taking Place on Sept. 19th (Business Wire) +8.84%
Sep-14-23 04:06AM Faraday Future Delivered Its Vehicle to Realtor and Netflix Star Jason Oppenheim at the "Delivery Co-Creation Day", Creating Boundary-Breaking Eco-Chemistry Among Ultra Luxury Homes, Ultra Luxury Cars, and Reality TV Show Industries (Business Wire) -8.30%
BIMI - BIMI International Medical Inc - Stock Price Chart
CompanyBIMI International Medical Inc
IndustryPharmaceutical Retailers
Market Cap6.83MEPS (ttm)-180.63
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y5.28%
P/S0.36EPS next 5Y-
P/B0.83EPS Q/Q99.87%
Dividend-Sales Q/Q70.33%
Insider Own31.93%Inst Own0.14%
Insider Trans0.00%Inst Trans20.95%
Short Float11.05%Earnings-
Analyst Recom-Target Price-
Avg Volume87.48K52W Range0.48 - 4.44